Catasys (CATS) Earning Somewhat Negative Press Coverage, Study Finds

Media coverage about Catasys (NASDAQ:CATS) has trended somewhat negative this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Catasys earned a daily sentiment score of -0.08 on Accern’s scale. Accern also assigned news articles about the company an impact score of 44.9162153651847 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Catasys (NASDAQ CATS) remained flat at $$4.66 on Monday. The stock had a trading volume of 7,429 shares, compared to its average volume of 77,355. Catasys has a 12-month low of $3.30 and a 12-month high of $14.00. The firm has a market cap of $74.04, a P/E ratio of -2.66 and a beta of 0.13.

Catasys (NASDAQ:CATS) last issued its earnings results on Tuesday, November 14th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.04). research analysts predict that Catasys will post -0.89 earnings per share for the current fiscal year.

A number of brokerages have recently issued reports on CATS. Telsey Advisory Group began coverage on shares of Catasys in a research report on Wednesday, October 18th. They issued a “buy” rating for the company. Taglich Brothers assumed coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “speculative buy” rating and a $8.00 price objective for the company. ValuEngine cut shares of Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st. Finally, Zacks Investment Research cut shares of Catasys from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th.

WARNING: This report was reported by Stock Observer and is the property of of Stock Observer. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.thestockobserver.com/2018/02/05/catasys-cats-earning-somewhat-negative-press-coverage-study-finds.html.

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Insider Buying and Selling by Quarter for Catasys (NASDAQ:CATS)

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply